CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services


CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services

February 8, 2015

Boston, MA – CMC Transaction Services, the life science focused investment bank, congratulates its client, IDEX Corporation (based in Lake Forest, IL), on its acquisition of CiDRA Precision Services, LLC (CPS). Located in Wallingford, CT, CiDRA Precision Services is a leader in the design, manufacture and sale of microfluidic components serving the life science, health and industrial markets. CMC Transaction Services acted as financial advisor to IDEX Corporation.“The CMC team did a wonderful job in helping us both to identify CiDRA Precision Services and structure the transaction,” commented Gustavo Salem, President, IDEX Health & Science. “CMC developed deep insights into the market leading technology and product portfolio of CPS, and then used this knowledge to secure a successful deal.” “The CPS transaction underscores the value of CMC’s integrated advisory approach,” stated Benjamin Conway, managing director of CMC Transaction Services. “Combining strategy consulting with M&A advisory services enables us to construct and implement strategic initiatives in a seamless and efficient fashion. The inherent advantage of the approach is of meaningful benefit to clients such as IDEX Corporation.”


About CMC Transaction Services, LLC.

CMC Transaction Services, LLC (formerly Johnston Blakely & Company), a CMC Group subsidiary, is a registered US broker/dealer focused on the life science sectors. CMC provides private equity capital brokerage and M&A advisory services to companies in the biotechnology, specialty pharmaceutical, medical device and diagnostic sectors and the ancillary services sectors. Member FINRA/SIPC


About CMC Consulting Group

The CMC Group is an international advisory firm providing integrated transaction services, management and medical affairs consulting and contract research to companies in the life science industries.  This integration provides clients a seamless interface between strategy and implementation and incorporates a range of perspectives designed to optimize engagement outcomes.  With offices in the United States, Asia and throughout the EU, the firm complements global industry knowledge with rich local market insight.